Search hospitals > California > Lancaster
City of Hope Antelope Valley
Claim this profileLancaster, California 93534
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
64 reported clinical trials
22 medical researchers
Summary
City of Hope Antelope Valley is a medical facility located in Lancaster, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. City of Hope Antelope Valley is involved with conducting 64 clinical trials across 133 conditions. There are 22 research doctors associated with this hospital, such as Alex F. Herrera, Tanya Dorff, MD, Marianna Koczywas, and Victoria Villaflor, Dr.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2
HER2 negative
Top PIs
Alex F. HerreraCity of Hope Medical Center5 years of reported clinical research
Expert in Lymphoma
Studies Hodgkin's Lymphoma
17 reported clinical trials
38 drugs studied
Tanya Dorff, MDCity of Hope Medical Center7 years of reported clinical research
Expert in Prostate Cancer
Studies Cancer
15 reported clinical trials
37 drugs studied
Marianna KoczywasCity of Hope Comprehensive Cancer Center4 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
14 reported clinical trials
21 drugs studied
Victoria Villaflor, DrCity of Hope Medical Center1 year of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
14 reported clinical trials
21 drugs studied
Clinical Trials running at City of Hope Antelope Valley
Lung Cancer
Non-Small Cell Lung Cancer
Diffuse Large B-Cell Lymphoma
Breast Cancer
Prostate Cancer
Cancer
Lymphoma
Brain Tumor
Squamous Cell Carcinoma
Hodgkin's Lymphoma
Telisotuzumab Vedotin vs. Docetaxel
for Non-Small Cell Lung Cancer
This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.
Recruiting2 awards Phase 312 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Whole Brain Radiotherapy + Stereotactic Radiosurgery
for Brain Metastasis
This phase III trial compares the effect of adding whole brain radiotherapy with hippocampal avoidance and memantine to stereotactic radiosurgery versus stereotactic radiosurgery alone in treating patients with cancer that has spread to the brain and come back in other areas of the brain after earlier stereotactic radiosurgery. Hippocampus avoidance during whole-brain radiation therapy decreases the amount of radiation that is delivered to the hippocampus, which is a brain structure that is important for memory. The medicine memantine is also often given with whole brain radiation therapy because it may decrease the risk of side effects of radiation on thinking and memory. Stereotactic radiosurgery delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Adding whole brain radiotherapy with hippocampal avoidance and memantine to stereotactic radiosurgery may be effective in shrinking or stabilizing cancer that has spread to the brain and returned in other areas of the brain after receiving stereotactic radiosurgery.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at City of Hope Antelope Valley?
City of Hope Antelope Valley is a medical facility located in Lancaster, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. City of Hope Antelope Valley is involved with conducting 64 clinical trials across 133 conditions. There are 22 research doctors associated with this hospital, such as Alex F. Herrera, Tanya Dorff, MD, Marianna Koczywas, and Victoria Villaflor, Dr.